Physician profile
Michael P Orourke
NPI 1447241799
$253.23
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $27.50 · 2023: $18.73 · 2024: $59.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $78.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $78.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $63.81 | 2019 | |
| Exact Sciences Corporation | $37.35 | 2023-2024 | Cologuard Collection Kit |
| Roche Diagnostics Corporation | $27.50 | 2020 | |
| Dexcom, INC. | $22.96 | 2024 | Dexcom G6 Transmitter |
| Ferring Pharmaceuticals INC. | $17.79 | 2024 | Euflexxa |
| Advanced Respiratory, INC | $14.00 | 2019 | |
| Genentech USA, INC. | $13.10 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.96 | 2019 | |
| Ironshore Pharmaceuticals INC. | $11.59 | 2019 | |
| Therapeuticsmd, INC. | $11.38 | 2019 | |
| Mylan Specialty L.P. | $10.99 | 2019 | |
| Abbvie INC. | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Orourke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.